Trial Profile
Metabolic Effects of an 8 Week Niaspan Treatment in Patients With Abdominal Obesity and Mixed Dyslipidemia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Oct 2023
Price :
$35
*
At a glance
- Drugs Niacin (Primary)
- Indications Dyslipidaemias; Obesity
- Focus Therapeutic Use
- 15 Oct 2010 New trial record